Connect with us

Health

A Skeptical G.O.P. Senator Makes His Peace With Kennedy

Published

on

A Skeptical G.O.P. Senator Makes His Peace With Kennedy

Perhaps no vote was as agonizing for Senator Bill Cassidy, the Louisiana Republican and medical doctor, than his vote to confirm Robert F. Kennedy Jr. as President Trump’s health secretary. Mr. Cassidy wondered aloud for days how Mr. Kennedy, the nation’s most vocal and powerful critic of vaccinations, might handle an infectious disease crisis.

Now, as a measles outbreak rages in West Texas, Mr. Cassidy has found out. It all comes down, he said, to “the gestalt.”

On Monday, days after the Texas outbreak killed an unvaccinated child, Mr. Cassidy, the chairman of the Senate Health Committee, was clipping down a Capitol corridor when he was asked about Mr. Kennedy. He pointed to a Fox News Digital opinion piece in which Mr. Kennedy advised parents to consult their doctors about vaccination, while calling it a “personal” decision.

“That Fox editorial was very much encouraging people to get vaccinated,” he said.

Reminded that Mr. Kennedy had described it as a personal choice, Mr. Cassidy thought for a moment. “If you want to like, parse it down to the line, you can say, ‘Discuss with your doctor,’” Mr. Cassidy said. “He also said, ‘We’re making vaccinations available. We’re doing this for vaccination. We’re doing that for vaccination.’ So if you take the gestalt of it, the gestalt was, ‘Let’s get vaccinated!’”

Advertisement

Mr. Cassidy’s assessment — that the whole of Mr. Kennedy’s message was more than the sum of its parts — reflects how the measles outbreak has put a spotlight on how Mr. Trump’s unorthodox choice to run the country’s top health agency has brought a once-fringe perspective into the political mainstream, creating discomfort for some Republicans.

As the founder and chairman of his nonprofit, Children’s Health Defense, and later as a presidential candidate, Mr. Kennedy has repeatedly downplayed the benefits of vaccination. He has also repeatedly suggested that the measles, mumps and rubella vaccine causes autism, despite extensive research that has found no link.

Since winning Trump’s nod to head the sprawling Department of Health and Human Services, Mr. Kennedy has walked a careful line on the issue. Some of his recent statements, in which he stops short of denouncing vaccines, have angered some of his supporters. But his less than full-throated endorsement of vaccination, and his promotion of alternative remedies to treat measles, have angered mainstream scientists who say the one proven way to prevent measles is the vaccine.

“This, I would say, is the barest of the bare minimum that one can do in the middle of a measles outbreak,” said Dr. Adam Ratner, a New York City pediatrician who just published a book, “Booster Shots,” that warns of a measles resurgence.

But Del Bigtree, Mr. Kennedy’s former communications director and one of his closest allies, said Mr. Kennedy was doing exactly what he said he would do: putting all options on the table and letting parents decide for themselves.

Advertisement

He used the word “balance” to describe Mr. Kennedy’s approach, and said the media was being “incredibly disingenuous and in some ways alarmist and dangerous by creating a panic over a death from measles.”

Asked about Mr. Cassidy’s “gestalt” remark, Andrew Nixon, a spokesman for the department, referred back to the Fox opinion piece. He said the health secretary’s comment could speak for itself: “Vaccines not only protect individual children from measles, but also contribute to community immunity, protecting those who are unable to be vaccinated due to medical reasons.”

Mr. Cassidy, a liver specialist, made his career in medicine treating uninsured patients as a doctor in Louisiana’s charity hospital system. He is a fierce proponent of vaccines.

But he is also facing a Republican primary challenger in 2026, and voting against Mr. Kennedy risked prompting Mr. Trump to endorse his opponent — and sparking a potential backlash among an increasingly vaccine-skeptical G.O.P. electorate.

Mr. Kennedy’s “medical freedom” movement, which he calls “Make America Healthy Again,” is now deeply entrenched in the Republican Party. The coronavirus pandemic turned many conservatives against vaccine mandates, even for children attending school. Around the country, nearly 1,000 candidates, nearly all Republican, ran for elective office in November with the backing of Stand for Health Freedom, a Florida nonprofit that has pushed to make it easier for parents to opt out of school vaccine requirements.

Advertisement

For Mr. Cassidy and other Republicans who were uneasy about Mr. Kennedy, the situation in West Texas is forcing a reckoning, said Whit Ayres, a Republican strategist who is also a member of Rotary International, an organization that has set a goal of ending polio by promoting vaccination around the world.

“His position on vaccines was exceedingly well known when he was nominated, and when he was confirmed by the United States Senate,” Mr. Ayers said. “Everybody, with their eyes open, knew that his positions could lead to a resurgence of measles.”

As vaccination rates have dropped around the country, public health experts have warned that measles would be the first infectious disease to come back. But the Texas measles outbreak cannot be blamed on Mr. Kennedy. The disease began spreading within the Mennonite community, an insular Christian group that settled in West Texas in the 1970s; many Mennonites are unvaccinated and vulnerable to the virus.

Mr. Kennedy minimized the situation in Texas during a Cabinet meeting with Mr. Trump last week, saying measles outbreaks in the United States are “not unusual.” His Fox opinion piece promoted the use of vitamin A, which studies have shown is useful in treating measles in malnourished children.

He followed up with a prerecorded Fox News interview that aired on Tuesday, in which he said parents and doctors should consider alternative approaches, including cod liver oil, for the treatment of measles. He also acknowledged that vaccines “do prevent infection.” But once again, Mr. Kennedy did not urge Americans to get vaccinated.

Advertisement

The Texas Department of Health issued a health alert on Jan. 23 reporting two cases of measles. Since then, nearly 160 people have contracted the illness and 22 have been hospitalized. The Centers for Disease Control and Prevention said Tuesday that it had sent some of its “disease detectives” to Texas to support local officials in the response.

By Wednesday, while Mr. Cassidy appeared satisfied with Mr. Kennedy’s handling of the matter, the senator was pushing another key health nominee on questions of measles, vaccines and autism.

He wanted to know whether Dr. Jay Bhattacharya, appearing before the Senate health committee for his confirmation hearing as Trump’s pick to lead the National Institutes of Health, intended to spend tax dollars on research into the discredited theory that vaccines cause autism. Mr. Cassidy had repeatedly, and unsuccessfully, tried to get Mr. Kennedy to reject that theory in his own confirmation hearing.

Dr. Bhattacharya told the senator he was “convinced” that there is no link between the measles vaccine and autism. But like Mr. Kennedy, he said he supported additional research, if only to assuage the fears of nervous parents.

Mr. Cassidy was incensed, saying the matter had already been settled by years of extensive research. New studies, he said, would waste taxpayer dollars and take away money from studies that might uncover the true causes of autism. He pounded his fist on the table.

Advertisement

“If we’re pissing away money over here,” he said with a wave of his hand, “that’s less money that we have to actually go after the true reason.”

And in any event, Mr. Cassidy said, further research would not change minds. “There’s people who disagree that the world is round,” he said, adding, “People still think Elvis is alive.”

To secure Mr. Cassidy’s vote last month, Mr. Kennedy made a series of concessions, which Mr. Cassidy outlined in a Senate floor speech. They included a pledge not to disband the committee of experts that advises the Centers for Disease Control and Prevention on vaccines, and to leave intact statements on the C.D.C.’s website saying that vaccines do not cause autism.

Mr. Kennedy also promised to have an “unprecedentedly close collaborative working relationship” with Mr. Cassidy, and to meet or speak with him “multiple times a month,” and to give Congress advance notice of any vaccine policy changes.

“I will carefully watch for any effort to wrongfully sow public fear about vaccines between confusing references of coincidence and anecdote,” Mr. Cassidy said then.

Advertisement

On his way into the Senate chamber on Monday, he said he thought Mr. Kennedy was doing a good job with the Texas response. “He’s handling it well,” the senator said. He was asked if he had spoken to Mr. Kennedy about the measles outbreak.

“We speak on a regular basis,” Mr. Cassidy said, adding: “Let’s leave it at that.”

Health

Aging process could accelerate due to ‘forever chemicals’ exposure, study finds

Published

on

Aging process could accelerate due to ‘forever chemicals’ exposure, study finds

NEWYou can now listen to Fox News articles!

A new study suggests that middle-aged men may be more vulnerable to faster biological aging, potentially linked to exposure to “forever chemicals.”

The research, published in the journal Frontiers in Aging, examined how perfluoroalkyl and polyfluoroalkyl substances, more commonly known as PFAS, could impact aging at the cellular level.

PFAS are synthetic chemicals commonly used in nonstick cookware, food packaging, water-resistant fabrics and other consumer products, the study noted. 

Their chemical structure makes them highly resistant to breaking down, allowing them to accumulate in water, soil and the human body.

Advertisement

Chinese researchers analyzed blood samples from 326 adults enrolled in the U.S. National Health and Nutrition Examination Survey between 1999 and 2000.

A new study suggests that middle-aged men could face accelerated biological aging at the cellular level due to exposure to PFAS. (iStock)

The researchers measured levels of 11 PFAS compounds in participants’ blood and used DNA-based “epigenetic clocks” — tools that analyze chemical changes to DNA to estimate biological age — to determine how quickly their bodies were aging at the cellular level, the study stated.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

Two compounds, perfluorononanoic acid (PFNA) and perfluorooctanesulfonamide (PFOSA), were detected in 95% of participants.

Advertisement

Higher concentrations of those chemicals were associated with faster biological aging in men of certain age groups, but not in women.

“People should not panic.”

The compounds most strongly linked to accelerated aging were not the PFAS chemicals that typically receive the most public attention, the researchers noted.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

“The associations were strongest in adults aged 50 to 64, particularly in men,” Dr. Xiangwei Li, professor at Shanghai Jiao Tong University School of Medicine and the study’s corresponding author, told Fox News Digital. 

Advertisement

“While this does not establish that PFAS cause aging, it suggests that these widely present ‘forever chemicals’ may be linked to molecular changes related to long-term health and aging.”

The study found that two of the compounds were detected in 95% of participants, and higher levels were linked to faster biological aging in men ages 50–64. (iStock)

Midlife may represent a more sensitive biological period, when the body becomes more vulnerable to age-related stressors, according to the researchers.

Lifestyle factors, such as smoking, may influence biological aging markers, potentially increasing vulnerability to environmental pollutants.

Advertisement

While Li said “people should not panic,” she does recommend looking for reasonable ways to reduce exposure. 

That might mean checking local drinking water reports, using certified water filters designed to reduce PFAS, and limiting the use of stain- or grease-resistant products when alternatives are available.

CLICK HERE FOR MORE LIFESTYLE STORIES

Meaningful reductions in PFAS exposure will likely depend on broader regulatory action and environmental cleanup efforts, Li added.

The researchers noted that midlife could be a particularly sensitive stage, when the body is more susceptible to stressors associated with aging. (iStock)

Advertisement

Study limitations

The researchers outlined several important limitations of the research, including that the findings show an association, but do not prove that PFAS directly causes accelerated aging.

“The study is cross-sectional, meaning exposure and aging markers were measured at the same time, so we cannot determine causality,” Li told Fox News Digital.

The study was also relatively small, limited to 326 adults age 50 or older, which means the findings may not apply to younger people or broader populations.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Researchers measured PFAS levels using data collected between 1999 and 2000, and today’s exposure patterns may differ.

Advertisement

Li added that while PFAS is known to persist in the environment and the body, these results should be validated through larger, more recent studies that follow participants over time.

Related Article

Nightly bathroom habit was missed sign of common men's cancer: 'I didn't know'
Continue Reading

Health

Melissa Joan Hart, 49, Opens up About Weight Loss in Perimenopause

Published

on

Melissa Joan Hart, 49, Opens up About Weight Loss in Perimenopause


Advertisement




Melissa Joan Hart Opens up About Weight Loss in Perimenopause | Woman’s World




















Advertisement





Advertisement


Use left and right arrow keys to navigate between menu items.


Use escape to exit the menu.

Advertisement

Continue Reading

Health

Alzheimer’s prevention breakthrough found in decades-old seizure drug

Published

on

Alzheimer’s prevention breakthrough found in decades-old seizure drug

NEWYou can now listen to Fox News articles!

A drug that has long been used to treat seizures has shown promise as a potential means of Alzheimer’s prevention, a new study suggests.

The anti-seizure medication, levetiracetam, was first approved by the FDA in November 1999 under the brand name Keppra as a therapy for partial-onset seizures in adults. The approval has since expanded to include children and other types of seizures.

Northwestern University researchers recently found that levetiracetam prevented the formation of toxic amyloid beta peptides, which are small protein fragments in the brain that are commonly seen in Alzheimer’s patients.

The medication was found to prevent the formation of amyloid-beta 42 in both animal models and cultured human neurons, according to the study findings, which were published in Science Translational Medicine.

Advertisement

The effect was also seen in post-mortem human brain tissue obtained from individuals with Down syndrome, who are at high risk for Alzheimer’s disease.

The medication was found to prevent the formation of amyloid-beta 42 in both animal models and cultured human neurons. (iStock)

“While many of the Alzheimer’s drugs currently on the market, such as lecanemab and donanemab, are approved to clear existing amyloid plaques, we’ve identified this mechanism that prevents the production of the amyloid‑beta 42 peptides and amyloid plaques,” said corresponding author Jeffrey Savas, associate professor of behavioral neurology at Northwestern University Feinberg School of Medicine, in a press release. 

“Our new results uncovered new biology while also opening doors for new drug targets.”

HIDDEN BRAIN CONDITION MAY QUADRUPLE DEMENTIA RISK IN OLDER ADULTS, STUDY SUGGESTS

Advertisement

The brain is better able to avoid the pathway that produces toxic amyloid‑beta 42 proteins in younger years, but the aging process gradually weakens that ability, Savas noted. 

“This is not a statement of disease; this is just a part of aging. But in brains developing Alzheimer’s, too many neurons go astray, and that’s when you get amyloid-beta 42 production,” he said. 

The effect was also seen in post-mortem human brain tissue obtained from individuals with Down syndrome, who are at high risk for Alzheimer’s disease. (iStock)

That then leads to tau (“tangles”) — abnormal clumps of protein inside brain neurons — which can kill brain cells, trigger neuroinflammation and lead to dementia.

In order for levetiracetam to function as an Alzheimer’s blocker, high-risk patients would have to start taking it “very, very early,” Savas said — up to 20 years before elevated amyloid-beta 42 levels would be detected.

Advertisement

CLICK HERE FOR MORE HEALTH STORIES

“You couldn’t take this when you already have dementia, because the brain has already undergone a number of irreversible changes and a lot of cell death,” the researcher noted.

The researchers also did a deep dive into previous human clinical data to determine whether Alzheimer’s patients who were taking the anti-seizure drug had slower cognitive decline. They reported that the patients in that category had a “significant delay” in the span from cognitive decline to death compared to those not taking the drug.

“This analysis supports the positive effect of levetiracetam to slow the progression of Alzheimer’s pathology,” the researcher said. (iStock)

“Although the magnitude of change was small (on the scale of a few years), this analysis supports the positive effect of levetiracetam to slow the progression of Alzheimer’s pathology,” Savas said.

Advertisement

Looking ahead, the research team aims to find people who have genetic forms of Alzheimer’s to participate in testing, Savas said.

Limitations and caveats

The study had several limitations, including that it relied on animal models and cultured cells, with no human trials conducted.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Because the study was observational in nature, it can’t prove that the medication caused the prevention of the toxic brain proteins, the researchers acknowledged.

Savas noted that levetiracetam “is not perfect,” cautioning that it breaks down in the body very quickly.

Advertisement

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

The team is currently working to create a “better version” that would last longer in the body and “better target the mechanism that prevents the production of the plaques.”

“You couldn’t take this when you already have dementia, because the brain has already undergone a number of irreversible changes and a lot of cell death.”

The medication’s common documented side effects include drowsiness, weakness, dizziness, irritability, headache, loss of appetite and nasal congestion.

It has also been linked to potential mood and behavior changes, including anxiety, depression, agitation and aggression, according to the prescribing information. In rare cases, it could lead to severe allergic reactions, skin reactions, blood disorders and suicidal ideation.

Advertisement

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Funding for the study was provided by the National Institutes of Health and the Cure Alzheimer’s Fund.

Fox News Digital reached out to the drug manufacturer and the researchers for comment.

Related Article

Alzheimer’s decline could slow dramatically with one simple daily habit, study finds
Continue Reading

Trending